Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).
about
Glucocorticoid-induced osteoporosisCharacteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort.The role of the combination of bone and fall related risk factors on short-term subsequent fracture risk and mortality.Overuse and Underuse of Antiosteoporotic Treatments According to Highly Influential Osteoporosis Guidelines: A Population-Based Cross-Sectional Study in Spain.Reasons for not initiating osteoporosis therapy among a managed care population.Low Osteoporosis Treatment Initiation Rate in Women after Distal Forearm or Proximal Humerus Fracture: A Healthcare Database Nested Cohort Study.Association between gastrointestinal events and osteoporosis treatment initiation in women diagnosed with osteoporosis in France: a retrospective analysisBeyond bone mineral density, FRAX-based tailor-made intervention thresholds for therapeutic decision in subjects on glucocorticoid: A nationwide osteoporosis survey.A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.Management of glucocorticoid-induced osteoporosis.Osteoporosis and treatments in Japan: management for preventing subsequent fractures.Review of new guidelines for the management of glucocorticoid induced osteoporosis.Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing's syndrome.Systematic scoping review of patients' perceived needs of health services for osteoporosis.Prevention and rehabilitation of osteoporosis.Disparities in osteoporosis treatments.Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996-2012.Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study.Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women.Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes.Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs.A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material.Low prevalence of osteoporosis treatment in patients with recurrent major osteoporotic fracture.An appendix to the 2012 IOF–ECTS guidelines for the management of glucocorticoid-induced osteoporosis
P2860
Q26778272-C436842F-F7E8-4BD7-969E-F6BEAFDD6797Q30564085-E54D56DD-8B44-4BBE-96C0-88C7268E0184Q34655156-F3D84D35-2779-43C3-AAD0-C2E34D8F1366Q35759160-83280087-E2B9-4184-AA7C-A5E27A8ABBBAQ35781017-593E431C-21A9-4599-9020-A748D2B08D6DQ35859130-DE78F6AE-AE00-47B0-9E56-AAF176C3C945Q36006735-2B1A4B91-D2A6-4E96-8963-584ED733E4CCQ37626620-B27A7E26-7649-40D5-BC79-8AF6BA534966Q37995500-E46E0E74-EF3D-4CC2-9213-006036DD03CBQ38033444-34E63735-15E9-419E-AEAA-4D9149CC60BCQ38093784-346B6DED-C735-4A7C-BBBE-D8817C50DCFBQ38151513-7E8B29D2-8FF4-401F-A134-AAF21342AE46Q38206066-14821DA2-D139-41F8-8F7A-E0253A46B247Q38420184-16C3348D-D69E-4A6F-8438-4E9452325C57Q38650053-7DD6AEC5-54AC-4965-B6DA-48AEDC482F4DQ38697335-4F2B696A-E066-4A73-A198-205F5DA115BDQ38980554-5425E8F3-2632-4A62-A1BC-20E22BF99753Q40772668-BE5737F4-F4E5-4C4F-A74F-E33BF9157873Q41717921-0D41AB87-6A3B-4EF3-85B2-C2FFAEC57509Q45000136-BD70BF07-0492-44E9-94A5-0308067A5A7DQ45797594-1C0B9B08-D6EA-42D5-9CA4-78C591D0B4CDQ47136618-F05DC1B2-780E-4D26-8E85-35048E80F702Q50922963-5804EB66-1B31-4B9B-8B3D-745A8E4CA3E8Q53469976-938B900F-3E82-4DC8-ABB4-D64F975EFC99Q57417002-385A9106-3920-44E7-B081-BA81A2213B9C
P2860
Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Regional differences in treatm ...... Osteoporosis in Women (GLOW).
@en
type
label
Regional differences in treatm ...... Osteoporosis in Women (GLOW).
@en
prefLabel
Regional differences in treatm ...... Osteoporosis in Women (GLOW).
@en
P2093
P2860
P1433
P1476
Regional differences in treatm ...... Osteoporosis in Women (GLOW).
@en
P2093
Adolfo Díez-Pérez
Andrea Z Lacroix
Christian Roux
Ethel S Siris
Frederick A Anderson
Frederick H Hooven
J Coen Netelenbos
Johannes Pfeilschifter
Jonathan D Adachi
Juliet E Compston
P2860
P304
P356
10.1016/J.BONE.2011.05.007
P577
2011-05-14T00:00:00Z